Not applicableNo Longer AvailableNCT02026934
What this trial is testing
CliniMACS® CD34+ Reagent System for Expanded Access Use
Who this might be right for
Graft-Versus-Host Disease(GVHD)Anemia Due to Disturbance of Proliferation and/or Differentiation of Hematopoietic Stem CellsGraft Failure+1 more
Joseph Antin